Effect of Avastin in Juxtafoveal Telangiectasias

Status Withdrawn

Clinical Trial Summary

Evaluation of efficacy of Intravitreal Injection of Bevacizumab in patients with Yuxtafoveal Telangiectasias

Clinical Trial Description

After diagnose Yuxtafoveal telangiectasias secondary to Branch Retinal Vein Occlusion and with Idiopathic Ethiology by clinical signs and Fluorescein angiogram (FA)findings we treated patients with Intravitreal Injection of Bevacizumab (2.5mg/0.1ml). We performed a complete ophthalmological evaluation and at baseline and follow-up (1 and 3 months) we evaluate ETDRS Best Corrected visual acuity (BCVA), fluorescein angiogram (FA) and Optical Coherence Tomography (OCT)findings. We found an improvement in visual acuity and reduction of FA leakage and decrease retinal thickness in OCT. ;

Study Design

Related Conditions & MeSH terms

Telangiectasis

Clinical Trial Details

NCT number	NCT00406380
Study type	Interventional
Source	Asociación para Evitar la Ceguera en México
Contact
Status	Withdrawn
Phase	Phase 3
Start date	September 2006
Completion date	November 2006

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT00005386` - Biobehavioral Determinants of Obesity in Black Women	N/A
Completed	`NCT00005392` - Epidemiology of Venous Disease	N/A
Completed	`NCT01205035` - High-Dose Lucentis (Ranibizumab 2.0mg) for the Treatment of Nonproliferative Idiopathic Parafoveal Telangiectasia	Phase 2
Completed	`NCT01362192` - Treatment of Lower Extremity Spider Veins With Excel V	Phase 4
Completed	`NCT00725244` - Trial of Endoscopy Bipolar and Argon of Chronic Rectal Bleeding From Radiation Telangiectasias	Phase 4
Withdrawn	`NCT02090517` - Laser Therapy Versus Electrosurgery For Nasal Telangiectasias	N/A
Completed	`NCT02657252` - Polidocanol Versus Glucose Treatment of Telangiectasia Trial	Phase 4
Completed	`NCT02104271` - Comparison Between Two Different Parameters of Argon Plasma Coagulation in the Treatment of Chronic Radiation Proctitis: Historical Control Trial.	Phase 2
Completed	`NCT00451763` - Intravitreal Bevacizumab for Idiopathic Macular Telangiectasia	Phase 3
Completed	`NCT05860439` - Lower Limb Sclerotherapy of Reticular Veins and Telangiectasias
Recruiting	`NCT00206921` - Pulsed Dye Laser and Intense Pulsed Light (IPL) for the Treatment of Telangiectasia and Skin Redness	N/A